Your rheumatologist can explain that current evidence does not support using these medications specifically for RA treatment
Also be wary of supplements that claim prescription-like effects without trial evidence
Alison Cave, the MHRAs Chief Safety Officer, emphasized the importance of informed decision-making: The decision to start, continue, or stop treatments should be made jointly by patients and their doctor, based on full consideration of benefits and risks. This statement underscores a key point: while the numbers are concerning, they must be contextualized within the millions of prescriptions issued and the complex health profiles of the patients taking these drugs
In a recent study carried out in health workers and medical students, 65% of nasal carriers of S
When subdivided into intention-to-treat and adherent patients, those maintaining medication use lost more weight at a peak of 12% TBW loss
The prior authorization process typically takes two to six weeks